{"schema_version":"secwatch.filing_event.v1","accession":"0000021665-26-000003","form_type":"8-K","ticker":"CL","cik":"0000021665","company_name":"COLGATE PALMOLIVE CO","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.288953+00:00","generated_at":"2026-05-16T06:09:52.964426+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment","bullets":["Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.","GAAP diluted EPS $2.63, down 25% YoY due to goodwill/intangibles impairment in skin health business.","Base Business EPS $3.69, up 3% YoY; record net cash from operations $4,198M.","Returned $2.9B to shareholders via dividends and share repurchases in FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000021665-26-000003","json":"https://secwatch.observer/filing/0000021665-26-000003.json","markdown":"https://secwatch.observer/filing/0000021665-26-000003.md","text":"https://secwatch.observer/filing/0000021665-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21665/000002166526000003/0000021665-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21665/000002166526000003/cl-20260130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:09:52.964426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}